文献速递脑血管病

ESCAPE试验:急性缺血性卒中大血管闭塞患者EVT后的健康相关生活质量

Health-Related Quality of Life Among Patients With Acute Ischemic Stroke and Large Vessel Occlusion in the ESCAPE Trial.
PubMed 文献 · Stroke · 2021-03-11

EVT组EQ-5D中位数显著高于对照组(0.80 vs 0.60,P<0.001),老年患者效应更明显,多个功能维度获益。

要点

  • EVT组90天EQ-5D中位数0.80,显著高于对照组的0.60(P<0.001)。
  • 年龄影响EVT对EQ-5D的效应,老年人效应量差异更大。
  • EVT组在自理、日常活动、行动维度及女性疼痛/不适维度症状无碍几率更高。

核心结论

  • 接受EVT的患者报告的健康相关生活质量显著改善,在老年个体中影响相对更大,并在多个维度观察到获益。

研究设计与样本

  • ESCAPE随机对照试验的二次分析,纳入165例随机至EVT和150例随机至对照的患者。
  • 在卒中后90天评估EuroQol-5D(EQ-5D),死亡赋值为0。

主要发现

  • EVT组EQ-5D中位数显著高于最佳药物治疗组(0.80 vs 0.60;P<0.001)。
  • 校正高龄死亡较多后,年龄对治疗效应有修饰作用,年龄越大EVT对EQ-5D的效应量差异越大。
  • 60至79岁接受EVT者在自理、日常活动和行动维度症状无碍的几率更高,女性在疼痛/不适维度更高,但与焦虑/抑郁无关联。
  • 90天严重残疾与较低EQ-5D相关,老年个体中关联更强,且该关联未被EVT修饰。

临床怎么用

  • EVT可显著改善急性缺血性卒中大血管闭塞患者90天健康相关生活质量,老年患者获益可能更明显。
  • 评估EVT获益时应关注多个功能维度,尤其是自理、日常活动和行动能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Endovascular thrombectomy (EVT) reduces 90-day disability in patients following acute ischemic stroke due to large vessel occlusion. Patient-reported outcome measures after EVT, such as health-related quality of life and specific functional domains, are less well described. METHODS: We report outcomes on the EuroQol-5D (EQ-5D) from the ESCAPE (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times) randomized controlled trial at 90 days after stroke. Death was assigned an index value of 0 for EQ-5D. We used quantile regression to evaluate the association between EVT and EQ-5D index scores and logistic regression for the association between EVT and symptom-free status among 90-day survivors for each EQ-5D dimension (self-care, usual activities, mobility, pain/discomfort, and anxiety/depression), assessing for modification by age or sex and adjusting for baseline factors including stroke severity, affected hemisphere, and receipt of alteplase. Lastly, the association between severe disability at 90 days and EQ-5D was evaluated with assessment for modification by EVT, age, and sex. RESULTS: There were 165 patients randomized to EVT and 150 patients randomized to control. Median EQ-5D was significantly higher for those who received EVT compared with best medical management (0.80 versus 0.60; P<0.001). After accounting for the greater number of deaths in the elderly, there was evidence of modification of treatment effect by age, with older age associated with a larger effect size difference in EQ-5D with EVT. Those receiving EVT had higher odds of symptom-free status in self-care, usual activities, mobility for those aged 60 to 79 years, and pain/discomfort for women, but there was no association with anxiety/depression. Severe disability at 90 days was associated with lower EQ-5D in older compared with younger individuals, and the association was not modified by EVT. CONCLUSIONS: Patients treated with EVT report substantially improved health-related quality of life, with relatively greater impact in older individuals and observed benefit across multiple dimensions.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Joundi RA, Rebchuk AD, Field TS, et al. Health-Related Quality of Life Among Patients With Acute Ischemic Stroke and Large Vessel Occlusion in the ESCAPE Trial. Stroke. 2021. PMID: 33691504. doi:10.1161/STROKEAHA.120.033872

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。